Homocysteine and its relationship to stroke subtypes in a UK black population: The south London ethnicity and stroke study

Stroke

Volumn 39, Issue 11, 2008, Pages 2943-2949

  Khan, Usman ^a   Crossley, Carollyn ^b   Kalra, Lalit ^c   Rudd, Anthony ^d   Wolfe, Charles D A ^e   Collinson, Paul ^b   Markus, Hugh S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c Department of Stroke Medicine ^*  (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Homocysteine; Leukoaraiosis; Stroke

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; VITAMIN B COMPLEX;

AGE DETERMINATION; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BRAIN DISEASE; BRAIN INFARCTION; CLINICAL TRIAL; COHORT ANALYSIS; COMMUNITY; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; ETHNICITY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY FUNCTION; LACUNAR INFARCTION; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; RISK FACTOR; SEX DETERMINATION; SMALL VESSEL DISEASE; STROKE; UNITED KINGDOM; VITAMIN BLOOD LEVEL; AGE; BLOOD; CEREBROVASCULAR DISEASE; ETHNOLOGY; GLOMERULUS FILTRATION RATE; MIDDLE AGED; NEGRO; PATHOLOGY; SEX DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; CEREBROVASCULAR DISORDERS; FOLIC ACID; GLOMERULAR FILTRATION RATE; HOMOCYSTEINE; HUMANS; LEUKOARAIOSIS; LONDON; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; STROKE; VITAMIN B COMPLEX;

EID: 55749102084     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.513416     Document Type: Article

References (34)

1. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111-128.
2. The Homocysteine Studies Collaboration. Homocysteine and risk of ischaemic heart disease and Stroke. A meta-analysis. JAMA. 2002;288: 2015-2022.
3. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002;325:1202.
4. Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost. 2005;94:907-915.
5. Hossain GS, van Thienen JV, Werstuck GH, Zhou J, Sood SK, Dickhout JG, de Koning AB, Tang D, Wu D, Falk E, Poddar R, Jacobsen DW, Zhang K, Kaufman RJ, Austin RC. TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the development of atherosclerosis in hyperhomocysteinemia. J Biol Chem. 2003;278:30317-30327.
6. Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ. 2004;11(Suppl 1):S56-S64.
7. Perini F, Galloni E, Bolgan I, Bader G, Ruffini R, Arzenton E, Alba S, Azzini C, Bartolomei L, Billo G, Bortolon F, Dudine P, Garofalo PG, L'Erario R, Morra M, Parisen P, Stenta G, Toso V. Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: stronger association with small artery disease. Neurol Sci. 2005;26:310-318.
8. Iso H, Moriyama Y, Sato S, Kitamura A, Tanigawa T, Yamagishi K, Imano H, Ohira T, Okamura T, Naito Y, Shimamoto T. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation. 2004;109:2766-2772.
9. Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI. Association between high homocyst (e) ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ische-mic stroke. Stroke. 2000;31:1069-1075.
10. Tan NC, Venketasubramanian N, Saw SM, Tjia HT. Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults. Stroke. 2002;33: 1956-1962.
11. Shimizu H, Kiyohara Y, Kato I, Tanizaki Y, Ueno H, Kimura Y, Iwamoto H, Kubo M, Arima H, Ibayashi S, Fujishima M Plasma homocyst (e) ine concentrations and the risk of subtypes of cerebral infarction. The Hisayama study. Cerebrovasc Dis. 2002;13:9-15.
12. Parnetti L, Caso V, Santucci A, Corea F, Lanari A, Floridi A, Conte C, Bottiglieri T. Mild hyperhomocysteinemia is a risk-factor in all etio-logical subtypes of Stroke. Neurol Sci. 2004;25:13-17.
13. Li Z, Sun L, Zhang H, Liao Y, Wang D, Zhao B, Zhu Z, Zhao J, Ma A, Han Y, Wang Y, Shi Y, Ye J, Hui R. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahy-drofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China. Stroke. 2003;34:2085-2090.
14. Bots ML, Launer LJ, Lindemans J, Hoes AW, Hofman A, Witteman JC, Koudstaal PJ, Grobbee DE. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med. 1999;159:38-44.
15. Khan U, Porteous L, Hassan A, Markus H. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry. 2007;78:702-706.
16. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol (Berl). 1968;12:1-15.
17. Boiten J, Lodder J, Kessels F. Two clinically distinct lacunar infarct entities? A hypothesis. Stroke. 1993;24:652- 656.
18. Hassan A, Hunt BJ, O'Sullivan M, Parmar K, Bamford JM, Briley D, Brown MM, Thomas DJ, Markus HS. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain. 2003;126: 424-432.
19. Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S, Bamford JM, Markus HS. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain. 2004;127: 212-219.
20. Stewart JA, Dundas R, Howard RS, Rudd AG, Wolfe CD. Ethnic differences in incidence of stroke: prospective study with stroke register. BMJ. 1999;318:967-971.
21. Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, Paik MC, Hauser WA. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol. 1998;147:259-268.
22. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke. 1995;26:14-20.
23. Markus HS, Khan U, Birns J, Evans A, Kalra L, Rudd AG, Wolfe CDA, Jerrard- Dunne P. Differences in stroke subtypes between black and white patients with stroke: the South London Ethnicity and Stroke Study. Circulation. 2007;116:2157-2164.
24. Kalra L, Rambaran C, Chowienczyk P, Goss D, Hambleton I, Ritter J, Shah A, Wilks R, Forrester T. Ethnic differences in arterial responses and inflammatory markers in Afro-Caribbean and Caucasian subjects. Arterioscler Thromb Vasc Biol. 2005;25:2362-2367.
25. Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, Paik MC. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the Northern Manhattan Study. Stroke. 2004;35:2263-2269.
26. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
27. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683-1689.
28. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet. 2005;365:224-232.
29. Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA. 2006;296:2720-2726.
30. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, Sun N, Liu L, Xu X. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet. 2007;369:1876 -1882.
31. Masuda J, Tanaka K, Omae T, Ueda K, Sadoshima S. Cerebrovascular diseases and their underlying vascular lesions in Hisayama, Japan-a pathological study of autopsy cases. Stroke. 1983;14:934-940.
32. Kluijtmans LA, Young IS, Boreham CA, Murray L, McMaster D, McNulty H, Strain JJ, McPartlin J, Scott JM, Whitehead AS. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood. 2003;101:2483-2488.
33. McAndrew PE, Brandt JT, Pearl DK, Prior TW. The incidence of the gene for thermolabile methylene tetrahydrofolate reductase in African Americans. Thromb Res. 1996;83:195-198.
34. Spence JD. Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol. 2007;6:830-838.